Bon Secours joins FDA’s Expanded Access Program to use convalescent plasma as a COVID-19 treatment

  • By cvbizz
  • April 22, 2020
  • 0
  • 60 Views

via foxcarolina.com

Share This Post!

Greenville, SC (FOX Carolina) – Wednesday, a spokesperson for Bon Secours announced they have joined the Food and Drug Administration’s national Expanded Access Program for convalescent plasma as a treatment protocol for COVID-19.

Convalescent plasma is plasma from a person who has recovered from the virus and is given to

Read Full Post


Upstate News Headlines

PHP Code Snippets Powered By : XYZScripts.com